| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |